
Quarterly report 2025-Q3
added 11-05-2025
Omnicell Net Debt 2011-2026 | OMCL
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Omnicell
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -327 M | -424 M | -280 M | -296 M | -6.53 M | -16.5 M | 68.2 M | 178 M | 200 M | -82.2 M | -126 M | -105 M | -62.3 M | -192 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 200 M | -424 M | -105 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Health information services industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
-12 M | - | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
4.65 B | - | - | $ 9.03 B | ||
|
Cerner Corporation
CERN
|
720 M | - | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
-178 M | $ 5.63 | -1.23 % | $ 90.3 M | ||
|
Computer Programs and Systems
CPSI
|
193 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
863 M | - | - | $ 2.94 B | ||
|
Castlight Health, Inc.
CSLT
|
-34.4 M | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
67.9 M | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
763 M | - | - | $ 6.37 B | ||
|
iCAD
ICAD
|
-16.8 M | - | - | $ 102 M | ||
|
Teladoc Health
TDOC
|
225 M | $ 5.55 | -0.36 % | $ 978 M | ||
|
Evolent Health
EVH
|
232 M | $ 2.28 | 0.66 % | $ 214 M | ||
|
10x Genomics
TXG
|
-264 M | $ 20.59 | -1.53 % | $ 2.41 B | ||
|
NextGen Healthcare
NXGN
|
-42.1 M | - | - | $ 1.6 B | ||
|
1Life Healthcare
ONEM
|
-41.2 M | - | - | $ 3.37 B | ||
|
OptimizeRx Corporation
OPRX
|
20.6 M | $ 7.11 | -0.97 % | $ 122 M | ||
|
MTBC
MTBC
|
-1.02 M | - | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
128 M | - | - | $ 2.33 B | ||
|
SCWorx Corp.
WORX
|
-376 K | $ 0.13 | -0.62 % | $ 190 K | ||
|
GoodRx Holdings
GDRX
|
44 M | $ 2.06 | -0.24 % | $ 795 M | ||
|
Schrödinger
SDGR
|
-121 M | $ 11.51 | 0.96 % | $ 845 M | ||
|
Signify Health
SGFY
|
-126 M | - | -0.02 % | $ 7.21 B | ||
|
HealthStream
HSTM
|
-39.3 M | $ 21.23 | - | $ 645 M | ||
|
R1 RCM
RCM
|
638 M | - | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
13.7 M | - | - | $ 161 M | ||
|
Streamline Health Solutions
STRM
|
2.4 M | - | - | $ 21.4 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
181 M | - | -10.39 % | $ 886 M | ||
|
Health Catalyst
HCAT
|
105 M | $ 1.09 | -0.72 % | $ 76.2 M | ||
|
NantHealth
NH
|
4.4 M | - | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
648 M | $ 84.15 | 2.04 % | $ 7.25 B | ||
|
Phreesia
PHR
|
-84 M | $ 11.54 | 2.67 % | $ 630 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-54.5 M | - | - | $ 255 M | ||
|
Progyny
PGNY
|
-143 M | $ 18.19 | 2.48 % | $ 1.56 B | ||
|
So-Young International
SY
|
-563 M | $ 3.11 | -2.51 % | $ 247 M | ||
|
Veeva Systems
VEEV
|
-1.33 B | $ 179.87 | 1.01 % | $ 29.4 B |